## New experimental pill shows promising results in killing many types of cancer

Authored by techspot.com

Bottom line: A drug capable of effectively treating multiple cancer types would be one of the greatest medical innovations in history.

Scientists at City of Hope have been working for years on something that could bring us very close to such a revolutionary breakthrough.

Currently undergoing human clinical trials, this drug could prove to be a highly effective therapy against one of the most formidable diseases humanity has ever faced.

It shows promise both as a standalone treatment and in combination with other chemotherapy drugs.

Malkas said that most therapies target a single pathway, enabling 'wily' cancer forms to mutate and eventually become drug-resistant.

The researchers tested AOH1996 in more than 70 cancer cell lines and several normal control cells, obtaining very promising results against cells derived from breast, prostate, brain, ovarian, cervical, skin, and lung cancers.

Currently, AOH1996 is undergoing phase 1 clinical trials to study its safety and efficacy in human patients. »

### The U.S. will abandon Europe. But when and how?

Authored by japantimes.co.jp

A sad trend in world affairs and one that is personal for me is the growing rift in the Atlantic.

I’m not talking about the geological one under the water (which widens by more than an inch per year) but about the geopolitical fault between the United States and Europe.

As a dual citizen of the U.S. and Germany, I’ve taken the trans-Atlantic bond for granted throughout my life. »

### China to retaliate after Trump fires first salvo in trade war

Authored by politico.eu

China’s statement is far less specific than the immediate responses from Mexico and Canada, whose leaders ordered countermeasures on Saturday.

Canadian Prime Minister Justin Trudeau said Ottawa would impose 25 percent tariffs on goods worth roughly $21 billion starting Tuesday and more later this month.

Meanwhile, Japan on Sunday expressed fears about the consequences of Trump’s tariffs for the global economy. »

### Fallout: New Vegas’s lead writer has re-joined Obsidian, but insists it’s not for a sequel

Authored by videogameschronicle.com

The lead writer of Fallout: New Vegas has returned to developer Obsidian, after 14 years away from the company.

John Gonzalez announced the news on his LinkedIn profile this week, confirming he’s taken up the role of creative director.

After his previous stint at Obsidian in 2008 – 2011, Gonzalez was notably a writer for Monolith’s Middle-Earth: Shadow of Mordor, the lead writer for Guerrilla’s Horizon: Zero Dawn, and narrative director for its sequel Forbidden West. »

### Former PlayStation Exec: Xbox Doesn’t Lose Anything in Multiplatform Approach

Authored by techcrawlr.com

In a recent chat with Gamertag Radio, Adam Boyes, who once led third-party relations at PlayStation, shared his thoughts on Microsoft’s evolving gaming approach.

He highlighted how Xbox is shifting from being just a console maker to becoming a broad entertainment provider.

He believes that expanding access doesn’t diminish the Xbox brand but strengthens it by bringing beloved franchises to a wider audience. »

## In pictures

## Also in the news

#### Trudeau announces 25 per cent retaliatory tariffs on U.S. goods starting Tuesday

#### Zelenskyy on NATO membership: Ukraine's 800,000-strong army would be a bonus to the alliance

#### Punxsutawney Phil predicts 6 more weeks of winter after waking up to see his shadow on Groundhog Day

#### More states outlaw the "exception clause"- FreedomUnited.org

#### David Hogg wins election as vice chair of DNC